Biological medicines for diffuse intrinsic pontine glioma (DIPG) eradication (BIOMEDE): Final results of an international randomized phase II platform trial comparing 3 targeted therapies in combination with radiotherapy from ITCC, SIOPE-Brain and ANZCHOG.

Jacques Grill, Gwenael Le Teuff, Pascale Varlet, Darren R. Hargrave, Karsten Nysom, Klas Blomgrenn, Geoffrey Brian McCowage, Francisco Bautista, Dannis Van Vuurden, Marie-Anne Debily, Thomas Kergrohen, Stephanie Puget, Stephanie Bolle, Samuel Abbou, Pierre Leblond, Nathalie Boddaert, Gilles Vassal, Marie-Cecile Le Deley

Open source

DOI: 10.1200/jco.2023.41.16_suppl.10003
Published: 2023-06-01
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.2023.41.16_suppl.10003,
  title = {Biological medicines for diffuse intrinsic pontine glioma (DIPG) eradication (BIOMEDE): Final results of an international randomized phase II platform trial comparing 3 targeted therapies in combination with radiotherapy from ITCC, SIOPE-Brain and ANZCHOG.},
  author = {Jacques Grill and Gwenael Le Teuff and Pascale Varlet and Darren R. Hargrave and Karsten Nysom and Klas Blomgrenn and Geoffrey Brian McCowage and Francisco Bautista and Dannis Van Vuurden and Marie-Anne Debily and Thomas Kergrohen and Stephanie Puget and Stephanie Bolle and Samuel Abbou and Pierre Leblond and Nathalie Boddaert and Gilles Vassal and Marie-Cecile Le Deley},
  year = {2023},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.2023.41.16_suppl.10003},
  url = {https://doi.org/10.1200/jco.2023.41.16_suppl.10003}
}

RIS

TY  - JOUR
TI  - Biological medicines for diffuse intrinsic pontine glioma (DIPG) eradication (BIOMEDE): Final results of an international randomized phase II platform trial comparing 3 targeted therapies in combination with radiotherapy from ITCC, SIOPE-Brain and ANZCHOG.
AU  - Jacques Grill
AU  - Gwenael Le Teuff
AU  - Pascale Varlet
AU  - Darren R. Hargrave
AU  - Karsten Nysom
AU  - Klas Blomgrenn
AU  - Geoffrey Brian McCowage
AU  - Francisco Bautista
AU  - Dannis Van Vuurden
AU  - Marie-Anne Debily
AU  - Thomas Kergrohen
AU  - Stephanie Puget
AU  - Stephanie Bolle
AU  - Samuel Abbou
AU  - Pierre Leblond
AU  - Nathalie Boddaert
AU  - Gilles Vassal
AU  - Marie-Cecile Le Deley
PY  - 2023
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.2023.41.16_suppl.10003
UR  - https://doi.org/10.1200/jco.2023.41.16_suppl.10003
ER  -

APA

Grill, J., Teuff, G. L., Varlet, P., Hargrave, D. R., Nysom, K., Blomgrenn, K., McCowage, G. B., Bautista, F., Vuurden, D. V., Debily, M., Kergrohen, T., Puget, S., Bolle, S., Abbou, S., Leblond, P., Boddaert, N., Vassal, G., & Deley, M. L. (2023). Biological medicines for diffuse intrinsic pontine glioma (DIPG) eradication (BIOMEDE): Final results of an international randomized phase II platform trial comparing 3 targeted therapies in combination with radiotherapy from ITCC, SIOPE-Brain and ANZCHOG.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2023.41.16_suppl.10003

Source records

crossref · retrieved 2026-11-10T14:18:25.690Z